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Abstract High-fat diet, exposure to saturated fatty
acids, or the presence of adipocytes in myoblast micro-
environment affects skeletal muscle growth and func-
tion. The aim of the present study was to investigate the
effect of palmitate supplementation on transcriptomic
profile of mouse C2C12myoblasts. Global gene expres-
sion was evaluated using whole mouse genome oligo-
nucleotide microarrays, and the results were validated
through qPCR. A total of 4047 genes were identified as
differentially expressed, including 3492 downregulated
and 555 upregulated genes, during a 48-h exposure to
palmitate (0.1 mmol/l). Functional classification
showed the involvement of these genes in several pro-
cesses which regulate cell growth. In conclusion, the
addition of palmitate modifies the expression of genes
associated with (1) myoblast responsiveness to hor-
mones and growth factors, (2) cytokine and growth
factor expression, and (3) regulation of cell-cell and
cell-matrix communication. Such alterations can affect
myoblast growth and differentiation; however, further
studies in this field are required.
Keywords Cytokines . Growth factors . Long-chain
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Abbreviations
Ccl Chemokine C-C motif
CxCl Chemokine C-X-C motif
CV Crystal violet
DMEM Dulbecco’s modified Eagle’s medium
DMSO Dimethylsulfoxide
FBS Fetal bovine serum





NF-κB Nuclear factor κB
PA Palmitate
qPCR Quantitative polymerase chain reaction
Wnt Wingless-Int
Introduction
Skeletal muscle is a key insulin-responsive tissue, which
is important for glucose and fatty acid utilization
(Houmard 2008). The fetal stage is crucial for skeletal
muscle development in humans and large farm animals
because there is no increase in muscle fiber number after
birth (Zhu et al. 2006). The skeletal muscle mass is,
therefore, closely related to the number of cells which
trigger the myogenic program and are able to undergo
hypertrophy at later stages of muscle development
(Bonnet et al. 2010).
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According to a recent study on human and animal
models, secondary myogenesis that mainly accounts for
muscle mass is susceptible to the availability of nutrients
and humoral factors and, thus, suboptimal fetal environ-
ments decrease the number of myofibers. Recent studies
revealed that maternal high-fat feeding and obesity in-
crease fat-to-lean mass ratio and cause impaired glucose
tolerance in offspring (reviewed in Warner and Ozanne
2010). Humoral factors associated with maternal obesity
can reduce fetal muscle fiber number and/or diameter and
promote adipogenesis and fibrogenesis (Du et al. 2010).
Downregulation of myogenesis and Wnt/β-catenin sig-
naling, probably resulting from activation of inflamma-
tory nuclear factor κB (NF-κB) pathway in fetal skeletal
muscle, has been reported in an obese pregnant sheep
model (Tong et al. 2009). Extracellular factors acting
during myogenesis control myoblast proliferation and
differentiation through regulation of signaling pathways
for the expression of specific transcription factors and
morphological changes (Le Grand and Rudnicki 2007).
According to the cell niche concept, myoblast behavior is
determined by the stimuli acting in the surrounding en-
vironment (Ohlstein et al. 2004), in which adipocyte-
derived fatty acids can be important signaling molecules.
These influences may, in turn, modify the expression and
secretion of factors which regulate numerous biological
processes in autocrine, paracrine, and endocrine manner
(Henningsen et al. 2010; Chan et al. 2011). Alterations in
muscle cell secretome during myogenic differentiation
support an important and active contribution of myo-
blasts in regulation of their microenvironment (Griffin
et al. 2010; Ge et al. 2013).
Microarray-based profiling enables the simultaneous
measurement of the expression of multiple genes and the
identification of genes and proteins that contribute to the
regulation of cellular processes. In the present study we
used a microarray technique for the comprehensive anal-
ysis of palmitate effect in mouse C2C12 myoblasts.
Global gene expression was evaluated using whole
mouse genome oligonucleotide microarrays, and the re-
sults were validated through real-time PCR. Gene ontol-
ogy analysis was used to classify gene functions. We
demonstrated that palmitate regulates genes involved in
different pathways associated with myoblast growth and
development, i.e., signal transduction, cell commitment,
differentiation, cell-cell and cell-matrix signaling, and
calcium homeostasis. These results can provide a basis
for future studies to investigate specific mediators of
effects of fatty acids on skeletal muscle growth.
Materials and methods
Preparing fatty acid-containing media
The solution of palmitate for the experimental treatment
was prepared by mixing with FFA-free bovine serum
albumin, as described by Coll et al. (2008). First, pal-
mitate (the sodium salt, obtained from Sigma-Aldrich),
was dissolved in ethanol and then diluted 1:100 in
Dulbecco modified Eagle’s medium (DMEM), supple-
mented with 2 % (w/v) fatty-acid free bovine serum
albumin. Palmitate complexed to BSA was added to
the experimental medium to obtain the final concentra-
tion of 0.1 mmol/l. This concentration of palmitate does
not mimic hyperlipidemic conditions; however, it does
not exert the toxic effect.
Cell culture
A research work was carried out on the murine myo-
genic C2C12 cell line (satellite cells from thigh muscle),
purchased from the European Collection of Animal Cell
Culture (ECACC). This cell line undergoes proliferation
and differentiation in response to growth factors present
in the extracellular environment; thus, it is a useful
model to study the mechanisms controlling myogenesis
(Yaffe and Saxel 1977).
Mouse C2C12 myoblasts were maintained free of
contamination at the exponential phase of growth in
DMEM supplemented with 10 % fetal bovine serum
(FBS) and an antibiotic-antimycotic mixture (Life
Technologies), in controlled humidified air supplement-
ed with 5 % CO2, at 37 °C. The growing medium was
changed every other day. After reaching ~40 % conflu-
ence, the proliferating myoblasts were subjected to 48-h
exposure to palmitate (0.1 mmol/l) added to 5 % FBS/
DMEM, according to the experimental protocol de-
scribed previously (Lee et al. 2009). The control cultures
were maintained in 5 % FBS/DMEM, containing the
same amounts of ethanol and FFA-free bovine serum
albumin, as the experimental medium.
Analysis of myoblast number
In order to verify the effect of palmitate supplementation
on cell number, C2C12 myoblasts were seeded onto
Petri dishes and cultured as described above. Changes
in cell number were monitored using a phase contrast
microscope (IX 70, Olympus Optical Co., Hamburg,
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Germany) and a Kodak DC 290 zoom digital camera
(Eastman Kodak Co., Rochester, NY, USA). The im-
ages of 10 independent visual fields for each dish were
captured before (0 h) and after the 48-h treatment, and
myoblast number in control and palmitate-treated cul-
tures were compared using the images related to the
same visual field. The results were presented as the
percentage of initial cell number.
Assessment of DNA content and cell respiration
A crystal violet (CV) assay was performed to determine
the total amount of nuclear DNA. The cells were cul-
tured in 96-well plates and fixed with 75 and 100 %
methanol for 20 min, and the monolayer was stained
using the crystal violet solution (2mg/ml) for 5 min. The
excess unbound dye was removed by washing the plates
with water. The bound crystal violet was released after
adding 1 % SDS for 30 min.
Viability of proliferating cells was determined using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay, as described previously
(Jacobson et al. 1994) with minor modifications. The
cells were seeded in 96-well plates, and after incubation
time, the MTT solution (0.5 mg/ml) in PBS was added
to each well. The plates were then incubated for 4 h at
37 °C. The reaction product, i.e., precipitated formazan,
was solubilized in 100 % DMSO (100 μl/well).
In both assays, the absorbance was measured on the
Infinite 200 PRO Tecan™ multidetection microplate
reader (Tecan, Mannedorf, Switzerland) at a wavelength
of 570 nm.
Microarray analysis
Total RNAwas extracted and purified from the C2C12
cells using the Total RNA kit (A&A Biotechnology,
Poland) according to the manufacturer’s protocol. The
isolated RNA samples were dissolved in RNase-free
water. The quantity of the isolated RNAwas measured
using NanoDrop (NanoDrop Technologies, USA). The
RNA samples were treated with DNase I to eliminate
DNA contamination and were subsequently purified
using the RNeasy MiniElute Cleanup Kit (Qiagen,
Germany). Subsequently, the RNA samples were ana-
lyzed on a BioAnalyzer (Agilent, USA) to measure the
final RNA quality and integrity. Total RNA (1000 ng)
from each sample was amplified and labeled using the
Quick Amp Labeling Kit (Agilent, USA) according to
the protocol for Agilent Gene Expression oligo micro-
arrays (version 5.7, March 2008). The Agilent Whole
Mouse Gene Expression (Mouse GE 4×44K version 2)
oligonucleotidemicroarray slide (containing fourmicro-
arrays; array ID 026655) was used for the hybridization.
Each microarray contained 39,485 oligonucleotide
probes that correspond with 27,122 of RefSeq (Entrez)
gene counts. The complementary RNA (cRNA) from
one control sample (labeled with cyanine-3) and one
experimental sample (labeled with cyanine-5) were hy-
bridized onto each microarray, resulting in the analysis
of RNAs from four control and four experimental cul-
tures. The hybridized microarrays were scanned on an
Agilent G2505C microarray scanner. Agilent Feature
Extraction (FE) software version 10.7.3.1 was used to
extract data, place microarray grids, reject outlier pixels,
accurately determine feature intensities and ratios, flag
outlier pixels, and calculate statistical confidences. The
statistical analysis was performed using the Gene Spring
12 software (Agilent, USA). The raw data were
preprocessed to remove variability across and within
array samples. To minimize the non-biological variabil-
ity across arrays, the raw data were first log2 trans-
formed. Total detected entities were filtered by flags
(detected, non-detected) and error (coefficient of varia-
tion: CV <50.0 %) to remove very low signal entities
and to select reproducible signal values of entities
among the replicated experiments.
Quantitative PCR
To validate the microarray data, the expression of four
genes (Arpc3, Tfpi,Usp47, Angptl4) was analyzed using
quantitative real-time PCR. The messenger RNA
(mRNA) gene sequences were obtained from the
National Center for Biotechnology Information
(NCBI) database, and the primers were designed using
the PRIMER3 software (free online access) and validat-
ed using Oligo Calculator (free online access) and
Primer-Blast (NCBI database). The primer sequences
are listed in Table 1. The Rpl13a gene was used as a
reference gene for the normalization of target gene
expression. The expression stability value of the house-
keeping gene Rpl13awas determined using the geNorm
and NormFinder programs. The M value equals 0.514
and the standard deviation equals 0.459.
The total RNAwas reverse transcribed to first strand
complementary DNA (cDNA) using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
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USA), following the manufacturer’s protocol. RT-PCR
was performed on a Stratagene Mx3005P quantitative
PCR instrument using the SYBR Select Master Mix
(Applied Biosystems, USA).
The qPCR program included preincubation step at
50 °C for 2 min and 95 °C for 2 min, and it was
continued with 40 cycles consisting of a denaturing step
at 95 °C for 15 s, an annealing step at 58 °C for 15 s, and
an elongation step at 72 °C for 30 s. All PCR reaction
efficiencies were between 92 and 105 %, and the prod-
uct melting curves showed single products and the
absence of a product in the negative controls.
The results were calculated using the 2−ΔΔCT method
(Livak and Schmittgen 2001). The expression changes
are shown as the relative upregulation or downregula-
tion normalized to the internal reference gene, Rpl13a.
The experiment was performed three times.
Statistical analyses
The results of the MTT and CV tests are representative
of four separate experiments performed in triplicate
(n=12). The results were presented as means±SE. For
each assay, the Student t test was used for the compar-
ison of two means (control vs experimental treatment)
and the criterion for statistical significance was P<0.05.
The analyses were performed using GraphPad Prism 5
(GraphPad Software, USA).
Differential gene expression was statistically ana-
lyzed using an unpaired t test to examine the null hy-
pothesis of no differential expression between the con-
trol and experimental groups. The statistical significance
was set at P≤0.05. Moreover, the Benjamini-Hochberg
false discovery rate (FDR) test, with a ≤0.05 signifi-
cance level, was employed. All significant changes with
fold-change absolute values greater than or equal to 1.6
were selected for ontological analyses. The data obtain-
ed from these analyses have been deposited in the NCBI
Gene Expression Omnibus and are accessible via GEO
Series accession number GSE75378. All genes signifi-
cantly altered in the analyses presented herein were
analyzed using commercial Pathway Studio software
(Agilent, USA). The Agilent microarray technology
used in this study is one of the most accurate, where
the minimum detectable fold change (MDFC) is be-
low 1.3 (Stafford 2008). The fold-change cutoff, in
the range of 1.6–2.0, is often used in the analysis of
microarray data (Morey et al. 2006; Munoz et al.
2012). This approach helped to avoid exclusion of
particularly interesting genes, which may display
slight expression changes associated with the perfor-
mance of their important biological function, from
further analyses (Lee 2001; Tarca et al. 2006). In
addition, it has been dictated by the results obtained
from the analysis of interactions between the ana-
lyzed genes carried in the Pathway Architect
(Agilent, USA), which showed that genes with sig-
nificant but low changes in expression can act as key
genes in the myogenesis process. Moreover, genes
with fold change equal or higher than 2 account for
only 6 % of total genes with significant changes in
expression after FDR correction. Genes with 1.6 fold
change in expression accounted for 61 % of all genes
with significant changes in expression.
Table 1 The primers used for qPCR
Gene symbol Primer sequence Optimum annealing temp. (°C) Source
Arpc3 (NM_019824) Fr: AACAGGAGGACGAGATGATG 58 Designed
Rv: CACCACTTGCTGGGTTTATC
Tfpi (NM_011576.1) Fr: AATTTTGGGACCTCATCTCC 58 Designed
Rv: AACTCGGGAACAAGGCTAAG
Usp47 (NM_133758.3) Fr: TGGATCACACCAGTGACAAG 58 Designed
Rv: GCAGTGGACCTATGAACCTG
Angptl4 (NM_020581) Fr: CTTTCCCTGCCCTTCTCTACT 58 Designed
Rv: ATGGCTACAGGTACCAAACCA
Rpl13a Fr: AATGTGGAGAAGAAAATCTGCAA 58 Designed
Rv: TCATTTTCAACACTGAAGCTCAA
The primers were designed using the PRIMER3 software (free online access) and checked using the Oligo Calculator (free online access)
and the Primer-Blast (NCBI database). The RPl13a gene was used as a non-regulated reference gene for normalization of the target gene
expression
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Results
Myoblast characteristics under palmitate treatment
The presence of palmitate (0.1 mmol/l) significantly de-
creased the number of myoblast in proliferating cultures
after the 48-h treatment (by 25.8 % in comparison to
control value, P=0.004, Fig. 1). This was confirmed by
the results of the crystal violet test (drop by 37.4 % vs
control value,P<0.0001) and lower cell viability (drop by
33.1 % below control value in MTT assay, P<0.0001).
Microarray analysis
Fold-change analysis with the absolute cutoff criteria set
at 1.6 followed by t test and Benjamini-Hochberg FDR
correction was used to identify 3492 transcripts that
were downregulated and 555 transcripts that were up-
regulated in palmitate-treated myoblasts. A total of 4047
of these genes were annotated for Mus musculus.
Validation of gene expression data by quantitative
real-time PCR
To validate the microarray data, we randomly selected
four genes significantly regulated by the presence of
palmitate with an absolute fold change of at least 2.0
(Table 2). The real-time PCR analysis showed expres-
sion pattern changes that were similar to those observed
in the microarray analysis, confirming the downregula-
tion ofArpc3 (actin-related protein 2/3 complex, subunit
3) and the upregulation of Usp47 (ubiquitin-specific
peptidase 47), Tfpi (tissue factor pathway inhibitor),
and Angtpl4 (angiopoietin-like 4).
In order to verify potential direct effects of palmitate
on gene expression, the mRNA levels of these genes
were measured at shorter time points (2, 6, 12, and 24 h,
Table 3). The presence of palmitate caused an increase
in Angtpl4 mRNAwithin a few hours. The expressions
of other genes were modified after either 12 (Usp47) or
24 h (Arpc3 and Tfpi). Moreover, the effects of palmitate
supplementation on Tfpi and Usp47 after 24 (Table 3)
and 48 h of treatment (Table 2) were opposite.
Gene ontology analysis
The gene ontology (GO) analysis assigns different genes
to different GO categories. Table 4 shows the major GO
biological processes and GO molecular function groups
associated with differentially expressed genes in myo-
blasts exposed to palmitate. The most significant path-
way in which the genes regulated in the presence of
Fig. 1 The characteristics of
mouse C2C12 myoblasts used in




(magnification ×100) of control
(Ctrl) and palmitate-treated (PA;
0.1 mmol/l) cultures. b The
results of myoblast counting are
shown as the percentage of the
initial cell number, n= 3. c DNA
content (crystal violet test) and d
cell viability (MTT assay) of
myoblasts exposed to palmitate
for 48 h, n = 12. The results
represent the mean± SE,
*Significantly different vs control
value
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palmitate were involved was the signal transduction.
The treatment of myoblasts with palmitate modified
the expression of 7–18 % of genes that play roles in
several biological processes associated with muscle cell
proliferation and growth. The addition of palmitate al-
tered the expression of 10–24 % of genes associated
with signal transducer activity, G-protein coupled recep-
tor, cytokine and growth factor activity, and
metallopeptidase function. Numerous identified genes
were involved in the metabolic process, which was not
unexpected, in view of the well-documented role of
saturated fatty acids in skeletal muscle metabolism.
According to the Panther classification, apoptosis is
beyond the Btop list^ of biological processes which are
highly enriched in genes affected by addition of palmi-
tate. In fact, we found Bpositive regulation of
apoptosis,^ with total entities amounting to 232, over-
lapping entities amounting to 21, and P=0.035, indicat-
ing a rather minor role of this process in the control of
myoblast number. The Panther analysis of identified
genes revealed that they were involved in numerous
intracellular pathways associated with cytokine/
chemokine and growth factors signaling and that the
majority of these genes was downregulated through
experimental treatment (Fig. 2).
Presence of palmitate affects the expression of genes
associated with cell communication
The treatment of C2C12 myoblasts with palmitate re-
sulted in the regulation of genes encoding cytokines
(Table 5) and growth factors (Table 6). The majority of
these genes were downregulated and were altered rather
slightly (absolute fold-change values below 2.0) by
palmitate supplementation. Ten of the differentially
expressed genes overlapped both GO categories.
Palmitate slightly but significantly downregulated 14
genes associated with metalloendopeptidase activity,
whereas seven genes belonging to this group were up-
regulated (Table 7).
Discussion
The mechanisms controlling skeletal muscle mass
and function as well as their potential modifications
through humoral factors acting during development
receive much attention. There are studies concerning
the effect of different concentrations of fatty acids on
the mechanisms controlling muscle cell growth and
differentiation, and the reported data differ depending
on experimental protocol. According to Lee et al.
(2009), palmitate (0.1–10 μmol/l) had no effect on
either proliferation or differentiation of C2C12
Table 2 The expression of randomly selected genes assessed by
microarray analysis and real-time qPCR in mouse C2C12 myo-
blasts treated for 48 h with palmitate (0.1 mmol/l)
Gene name cDNA microarray Real-time qPCR
Arpc3 −3.9 0.8 ± 0.09*
Tfpi 2.1 1.59 ± 0.20*
Usp47 2.0 1.26 ± 0.15*
Angptl4 2.8 1.93 ± 0.25*
The expression changes are shown as relative up- or downregula-
tion normalized by the internal reference gene (Rpl13a). The data
from three separate experiments were used to calculate the means
± SE
*Significantly different vs control value (P< 0.05)
Table 3 The expression of randomly selected genes assessed by real-time qPCR in mouse C2C12 myoblasts treated for 2, 6, 12, and 24 h
with palmitate (0.1 mmol/l)
Gene name Time
2 h 6 h 12 h 24 h
Arpc3 0.96± 0.04 0.95± 0.11 0.91 ± 0.05 0.55 ± 0.02*
Tfpi 1.21± 0.26 0.83± 0.18 0.87 ± 0.05 0.65 ± 0.02*
Usp47 1.1 ± 0.24 0.81± 0.23 0.69 ± 0.07* 0.47 ± 0.03*
Angptl4 2.38± 0.05* 2.99± 0.21* 3.98 ± 0.25* 2.96 ± 0.12*
The expression changes are shown as relative up- or downregulation normalized by the internal reference gene (Rpl13a). The data from three
separate experiments were used to calculate the means ± SE
*Significantly different vs control value at the same time point (P< 0.05)
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Table 4 Gene ontology groups enriched in the differentially expressed genes in mouse C2C12 myoblasts exposed to palmitate (0.1 mmol/l)
for 48 h
Total entities Overlap Corrected P value
Biological processes
Signal transduction, GO:0007165 3586 675 0.000017
Metabolic processes, GO:0008152 2421 184 0.000589
Cell differentiation, GO:0030154 735 84 0.000226
Cell adhesion, GO:0007155 686 71 0.000413
Proteolysis, GO:0006508 657 62 0.000597
Inflammatory response, GO:0006954 316 39 0.000492
Cell-cell signaling, GO:0007267 281 38 0.000380
Cellular Ca2+ homeostasis, GO:0006874 94 12 0.006141
Cell fate commitment, GO:0045165 70 11 0.000924
Myofibril assembly, GO:0030239 7 3 0.003370
Molecular functions
Signal transducer activity, GO:0004871 1678 405 0.000031
G-prot.-coupled receptor activity, GO:0004930 1653 396 0.000046
Cytokine activity, GO:0005125 232 32 0.000156
Growth factor activity, GO:0008083 190 26 0.001322
Metallopeptidase activity, GO:0004222 142 21 0.001336
Biological process and molecular function groups from gene ontology were found using Pathway Studio 7.1 from Ariadne Genomics. The
results (corrected P value cutoff ≤0.05) were sorted based on the number of genes involved in each group. The absolute fold-change cutoff
was set at 1.6
Fig. 2 Signaling pathways enriched by differentially expressed
genes in mouse C2C12 myoblasts exposed for 48 h to palmitate
(PA, 0.1 mmol/l). The analysis was performed using the Panther
classification system. The results were sorted by P value (cutoff
≤0.05) and absolute fold change (cutoff ≤1.6)
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myoblasts during the 48-h exposure. At the begin-
ning of our experiments, we used a higher concen-
tration of palmitate, i.e., 0.5 mmol/l, which is known
to cause insulin resistance in muscle cells (Alkhateeb
et al. 2007; Coll et al. 2008; Bakhtiyari et al. 2010;
Feng et al. 2012). However, this concentration ap-
peared highly toxic for proliferating myoblasts (not
shown); therefore, finally, we decided to treat cell
Table 5 Palmitate-regulated genes associated with cytokine activity (molecular function GO:0005125)
No. Fold change Gene ID Description
Downregulated
1. −1.62 IfnB1 Mus musculus interferon beta 1, mRNA (NM_010510)
2. −1.62 CD40lg M. musculus CD40 ligand, mRNA (NM_011616)
3. −1.64 Gdf2 M. musculus growth differentiation factor 2, mRNA (NM_019506)
4. −1.65 Il25 M. musculus interleukin 25, mRNA (NM_080729)
5. −1.65 Pglyrp1 M. musculus peptidoglycan recognition protein 1, mRNA (NM_009402)
6. −1.66 Mstn M. musculus myostatin, mRNA (NM_010834)
7. −1.66 Ccl22 M. musculus chemokine (C-C motif) ligand 22, mRNA (NM_009137)
8. −1.67 Il12B M. musculus interleukin 12b, mRNA (NM_008352)
9. −1.67 Prl7d1 M. musculus prolactin family 7, subfamily d, member 1, mRNA (NM_011120)
10. −1.67 Il23A M. musculus interleukin 23, alpha subunit p19, mRNA (NM_031252)
11. −1.67 Il1F8 M. musculus interleukin 1 family, member 8, mRNA (NM_027163)
12. −1.68 Csf2 M. musculus colony stimulating factor 2 (granulocyte-macrophage), mRNA (NM_009969)
13. −1.68 Cxcl3 M. musculus chemokine (C-X-C motif) ligand 3, mRNA (NM_203320)
14. −1.69 Xcl1 M. musculus chemokine (C motif) ligand 1, mRNA (NM_008510)
15. −1.70 Il22 Synonym: M. musculus interleukin 10-related T cell-derived inducible factor beta, mRNA (NM_054079)
16. −1.70 Ccl26 M. musculus chemokine (C-C motif) ligand 26, mRNA (NM_001013412)
17. −1.70 Il9 M. musculus interleukin 9, mRNA (NM_008373)
18. −1.70 Il1f5 M. musculus interleukin 1 family, member 5 (delta), transcript variant 1, mRNA (NM_001146087)
19. −1.72 IfnK M. musculus interferon kappa, mRNA (NM_199157)
20. −1.72 Tnfsf4 M. musculus tumor necrosis factor (ligand) superfamily, member 4, mRNA (NM_009452)
21. −1.74 Ifna4 M. musculus interferon alpha 4, mRNA (NM_010504)
22. −1.78 Bmp5 M. musculus bone morphogenetic protein 5, mRNA (NM_007555)
23. −2.01 Il12a M. musculus interleukin 12a, transcript variant 1, mRNA (NM_001159424)
Upregulated
24. 1.64 InhbB M. musculus inhibin beta-B, mRNA (NM_008381)
25. 1.66 Osm M. musculus oncostatin M, mRNA (NM_001013365)
26. 1.67 Wnt2 M. musculus wingless-related MMTV integration site 2, mRNA (NM_023653)
27. 1.76 CD70 M. musculus CD70 antigen, mRNA (NM_011617)
28. 1.99 Tnfsf14 M. musculus tumor necrosis factor (ligand) superfamily, member 14, mRNA (NM_019418)
29. 2.04 Faslg M. musculus Fas ligand (TNF superfamily, member 6), transcript variant 1, mRNA (NM_010177)
30. 2.66 Il17a M. musculus interleukin 17A, mRNA (NM_010552)
31. 2.69 Bmp6 M. musculus bone morphogenetic protein 6, mRNA (NM_007556)
32. 2.73 LtB M. musculus lymphotoxin B, mRNA (NM_008518)
Mouse C2C12 myoblasts were exposed to palmitate (0.1 mmol/l) for 48 h. Data were analyzed using the Gene Spring software (Agilent,
USA). The absolute fold-change cutoff was set at 1.6
P value ≤ 0.05
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cultures with fatty acid salt at concentration of
0.1 mmol/l.
In our recent study, palmitate was found to inhibit
proliferation of myoblasts through a decrease in cy-
clin A and cyclin D1 levels and an increase in p21-
cdk4 complex formation, however, it promoted cell
cycle exit, myogenic differentiation, and myotube
growth (Grabiec et al. 2015). On the other hand,
fatty acid-induced stimulation of protein degradation
via the ubiquitin-proteasome pathway and inhibition
of protein synthesis through the increased phosphor-
ylation of eukaryotic initiation factor 2 (eIF2) in
skeletal muscle cells have already been described
(Zhou et al. 2007). Such observations prompt the
hypothesis that the effects of palmitate of skeletal
myoblasts could be secondary, due to the modulation
of cell response to environmental stimuli. According
to our results, palmitate, a fatty acid present in blood
plasma and in skeletal muscle tissue (Chavez and
Summers 2003), appeared as a Bpleiotropic^ factor
which affects expression of numerous genes impor-
tant for cellular processes associated with muscle cell
growth and metabolism. It should be noticed that
palmitate-mediated modification of gene expression
was rather slight, as the absolute fold-change values
were usually below 2.0. However, the differences
between control and palmitate-treated cells were ob-
served at 48 h of exposition, and it is likely that this
effect would become more evident in prolonged
experiment.
The addition of palmitate affects the expression of
genes involved in signal transduction pathways of
hormones, cytokines, and growth factors (Table 4).
The most significant process enriched in the differ-
entially expressed genes in C2C12 myoblasts treated
with palmitate was the signal transduction. The ma-
jority of genes with expression altered by palmitate
treatment display the functions of a signal transducer
and G-protein coupled receptors (Table 4). Decreased
expression of genes related to important signaling
pathways can result in impaired responsiveness of
palmitate-treated myogenic cells to hormones and
growth factors. In fact, a high-fat diet or acute expo-
sure to palmitate caused insulin resistance and the
relevant mechanisms have already been described
(Delarue and Magnan 2007; Alkhateeb et al. 2007).
The microarray analysis in our study revealed the
palmitate-exerted modification of signaling pathways
important for mediating effects of hormones and
growth factors (Fig. 2), as well as for inflammatory
response (Table 4). This is in agreement with recent
reports on increased protein tyrosine phosphatase-1B
(Bakhtiyari et al. 2010), decreased phosphorylation
of Akt (Feng et al. 2012), or activation of NF-κB
(Zhang et al. 2010) in palmitate-treated myogenic
cells.
Other biological processes which were significant-
ly associated with genes modified in palmitate-
treated myoblasts included cell adhesion, cell-cell
signaling, and cellular Ca2+ homeostasis (Table 4).
Cell-matrix and cell-cell adhesions are essential for
most cell types during development and normal cell
function, as they regulate cell polarity, migration, and
differentiation (Krauss et al. 2005; Lei et al. 2013).
Genes altered in the presence of palmitate were asso-
ciated with integrin, cadherin signaling, plasminogen
activation, and cytoskeletal regulation (Fig. 2).
Calcium homeostasis appeared to be important in
the maintenance of mechanisms promoting the ex-
pression of muscle-specific proteins and myoblast
fusion (Mancinelli et al. 2012). Another pathway
enriched by differentially expressed genes in
palmitate-treated myoblasts is Wnt signaling, which
is important for early development and commitment
of myogenic cells (Otto et al. 2008). Palmitate sup-
plementation downregulated the majority of genes
associated with the Wnt pathway (Fig. 2) and is in
agreement with the idea presented by Du et al. (2010)
concerning the inhibitory effect of maternal obesity
on Wnt/beta-catenin signaling, leading to impairment
of fetal myogenesis.
The addition of palmitate modifies the expression
of genes encoding cytokines, growth factors, and
genes related to extracellular matrix. These results
raise the possibility that modification of myoblast
secretome, that is, cytokine/growth factor release,
by palmitate could serve as a mechanism of impact
on myoblast growth. It is partially supported by the
present results of selected genes’ expression of short-
time vs 48-h treatment with palmitate. Only the
Angtpl4 mRNA levels were increased by palmitate
within a few hours (Table 3). The inhibitory effect on
Arpc3 appeared after the 24-h exposure; moreover,
the effects of fatty acid supplementation on Tfpi and
Usp47 after 24 (Table 3) and 48 h of treatment
(Table 2) were opposite. This suggests that the effects
of palmitate treatment observed after 48 h may be
mainly due or may be superposed by the effects
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resulting from autocrine stimulation of cytokines/
growth factors released by the myoblasts.
We showed a decrease in the expression of genes
associated with cytokine and growth factor activity
(Tables 5 and 6). This finding confirms the ability of
myogenic cells to express bioactive factors, such as
interleukins (Pedersen and Febbraio 2008),
chemokines (Griffin et al. 2010; Ge et al. 2013;
Grzelkowska-Kowalczyk et al. 2015), fibroblast
growth factors (Hojman et al. 2009) and ADAMTS-
like proteins (Koo et al. 2007), plasminogen activator
(Francis et al. 2014), and proteoglycans (Li and
Velleman 2009), involved in the regulation of muscle
development and vascularization (Novak et al. 2011).
It is in agreement with other recent observations
reporting that saturated fatty acids are able to induce
proinflammatory cytokine production (Miao et al.
2015a), through the activation of transcription fac-
tors, such as nuclear factor NF-κB, forkhead box-
containing protein FOXO-1, or hypoxia-inducible
factor HIF-1α (Lee et al. 2014; Miao et al. 2015b).
Interestingly, high-fat diet-induced release of inflam-
matory cytokines can be modulated by polyunsatu-
rated fatty acid supplementation; nevertheless, the
exact roles of n3 and n6 fatty acids are not clear
(Sundaram et al. 2015). Such results, once again,
support the indirect mechanisms of fatty acid action.
The presence of palmitate affected genes encoding
cytokines and chemokines which have already been
investigated in myoblasts (Griffin et al. 2010), such
as Bmp6, Csf2, Xcl1, Inhbb, and Tnfsf14 (Tables 5
and 6). Moreover, in palmitate-treated myoblasts, we
found modification of numerous genes encoding cy-
tokines and chemokines, which, to our knowledge,
had not been previously known to be expressed by
skeletal muscle cells, i.e., Ccl22, Ccl28, Cxcl3, IL-
12a, IL-12b, IL-17a, IL-22, IL-23a, and IL-25
(Table 5). The exact roles of these factors in muscle
cell growth and differentiation require further
research.
Some of the experimentally modified genes seem
to be particularly interesting, since they are known
regulators of myoblast proliferation and differentia-
tion. Neuregulins have been described as myokines
that exert relevant effects on myogenesis and the
regulation of muscle metabolism (Gumà et al.
2010; Juretić et al. 2012). Oncostatin M (OSM), an
IL-6 family cytokine, inhibits proliferation of myo-
blasts by cyclin D1 protein reduction (Kim et al.
2008) and inhibits myoblast differentiation via
downregulation of MyoD and MEF2 transcription
activity and stimulation of Id1 and Id2 proteins
(Xiao et al. 2011). Interestingly, the presence of
palmitate slightly downregulated myostatin, a nega-
tive factor for muscle cell growth and differentia-
tion, and upregulated genes encoding health benefit
myokines (Table 6). The protein products of Fgf21
and Chia counteract cytokine-mediated inflamma-
tion and insulin resistance in skeletal muscle (Lee
et al. 2012; Görgens et al. 2014). In our study,
exposure to palmitate upregulated the expression of
genes encoding these factors (Table 6), suggesting
the complex alteration of myoblast microenviron-
ment. Recently, Yang et al. (2013) found a negative
effect of high palmitate (0.2–0.6 mmol/l) on C2C12
myotubes, manifested by a drop in expression of the
health benefit myokines (FGF21, FnDC5, CTRP15).
This apparent discrepancy with our results indicates
that the effects of palmitate on myogenic cell
secretome could be dose dependent. Alternatively,
these differential effects could result from different
susceptibility of myotubes and myoblasts to palmi-
tate, or could indicate indirect effects, which appear
during 48 h of treatment.
Another group enriched with genes modified by pal-
mitate supplementation was associated with
metalloendopeptidase activity (Table 7). We found sev-
eral genes encoding ADAM, ADAMTS, and
ADAMTS-like proteins, which were already described
in differentiating C2C12 myocytes (Henningsen et al.
2010). Among the metallopeptidases, downregulated by
palmitate in myoblasts was fibroblast activation protein
(Fab), an integral membrane serine peptidase. The role
of Fab in myogenic cells is unknown; however, this
protein is crucial for tumor invasion and metastasis
(Ding et al. 2014). It therefore cannot be excluded that
the decreased expression of Fab inmyoblasts affects cell
abilities of matrix adhesion and migration and, in turn,
cellular growth.
In conclusion, the results of our study indicate that
addition of palmitate, whether acting directly or in-
directly, can modify expression of genes associated
with (1) myoblast responsiveness to hormones and
growth factors, (2) cytokine and growth factor ex-
pression, and (3) regulation of cell-cell cell-matrix
communication. Such alterations can affect myoblast
growth and differentiation; however, further studies
in this field are required.
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